A carregar...
SARS-CoV-2 and DPP4 inhibition: Is it time to pray for Janus Bifrons?
Diabetes could be a risk factor for severity and mortality in patients with coronavirus disease 2019 COVID-19. It has been hypothesized that DPP4 inhibition, a therapy currently available for type 2 diabetes, might represent a target for decreasing the risk of the acute respiratory complications of...
Na minha lista:
| Publicado no: | Diabetes Res Clin Pract |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier B.V.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7179491/ https://ncbi.nlm.nih.gov/pubmed/32335097 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.diabres.2020.108162 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|